Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-05-23 00:00:00 ET · period of report 2025-05-22 · accession 0001415889-25-014467 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-23 | 2025-05-22 | FENC | Andrade Robert | CFO | M - OptEx | $5.10 | +8,220 | 158.5K | +5% | +$41.9K |
| D | 2025-05-23 | 2025-05-22 | FENC | Andrade Robert | CFO | M - OptEx | $5.10 | -8,220 | 850.8K | -1.0% | -$41.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2025-05-22 | M | A | 8,220 | $5.10 | 158,520 | D | — | — | (F1) Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027. |
| 2 | Derivative | Stock Options | 2025-05-22 | M | D | 8,220 | $5.10 | 850,751 | D | $5.10 · 2017-06-27 to 2027-06-27 | 8,220 Options | (F1) Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027. |